RxDoctor Payments Data

Edna Frazier

Family · Columbia, SCNPI 1215649660

Payments from drug & device makers

$373in general payments, 2019–2025

Across 19 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$160
  • Electronic Waveform Lab, Inc.$55
  • Saluda Medical Americas, Inc.$42
  • Protega Pharmaceutials Inc$38
  • Alnylam Pharmaceuticals Inc.$29
  • Forte Bio-pharma LLC$28
  • plus $22 from 1 others

What the payments were for

  • Food & beverage$373100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$160
Electronic Waveform Lab, Inc.3$55
Saluda Medical Americas, Inc.2$42
Protega Pharmaceutials Inc2$38
Alnylam Pharmaceuticals Inc.1$29
Forte Bio-pharma LLC2$28
Boston Scientific1$22

How this compares

$373 in reported general payments places this provider in the 45th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$21,217
Medicare patients
88
Services billed
289

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin186$2,093
Lidocaine24$1,715
Tizanidine Hcl91$1,129
Cyclobenzaprine Hcl116$886
Diclofenac Sodium27$459
Methocarbamol37$279
Meloxicam57$279
Baclofen18$260
Duloxetine Hcl16$176
Methylprednisolone15$93
Celecoxib11$44

Paid to pharmacies, not to this prescriber.

Other family in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →